Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 188

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling

Open access
Chiang, Chi-Fu, Chao, Ting-Ting, Su, Yu-Fu, Hsu, Chia-Chen, Chien, Chu-Yen, Chiu, Kuo-Chou, Shiah, Shine-Gwo, Lee, Chien-Hsing, Liu, Shyun-Yeu, Shieh, Yi-Shing · 2017 · Oncotarget

Abstract

// Chi-Fu Chiang 1 , Ting-Ting Chao 2 , Yu-Fu Su 3 , Chia-Chen Hsu 1 , Chu-Yen Chien 1 , Kuo-Chou Chiu 4 , Shine-Gwo Shiah 5 , Chien-Hsing Lee 6 , Shyun-Yeu Liu 7 , Yi-Shing Shieh 4, 8 1 Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan 2 Medical Research Center, Cardinal Tien Hospital, School of Medicine, New Taipei City, Taiwan 3 Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan 4 Department of Dentistry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan 5 National Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan 6 Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan 7 Department of Oral and Maxillofacial Surgery, Chi Mei Medical Center, Tainan, Taiwan 8 Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan Correspondence to: Yi-Shing Shieh, email: ndmcyss@ndmctsgh.edu.tw Chien-Hsing Lee, email: doc10383@gmail.com Shyun-Yeu Liu, email: syliu@mail.chimei.org.tw Keywords: breast cancer, macrophage polarization, metformin, microenvironment, NF-κB Received: December 15, 2016 Accepted: January 24, 2017 Published: February 01, 2017 ABSTRACT Accumulating evidence is indicating metformin to possess the potential ability in preventing tumor development and suppressing cancer growth. However, the exact mechanism of its antitumorigenic effects is still not clear. We found that metformin suppressed the ability of cancer to skew macrophage toward M2 phenotype. Metformin treated cancer cells increased macrophage expression of M1-related cytokines IL-12 and TNF-α and attenuated M2-related cytokines IL-8, IL-10, and TGF-β expression. Furthermore, metformin treated cancer cells displayed inhibited secretion of IL-4, IL-10 and IL-13; cytokines important for inducing M2 macrophages. Conversely, M1 inducing cytokine IFN-γ was upper-regulated in cancer cells. Additionally, through increasing AMPK and p65 phosphorylation, metformin treatment activated AMPK-NF-κB signaling of cancer cells that participate in regulating M1 and M2 inducing cytokines expression. Moreover, Compound C, an AMPK inhibitor, significantly increased IL-4, IL-10, and IL-13 expression while BAY-117082, an NF-κB inhibitor, decreased expression. In metformin-treated tumor tissue, the percentage of M2-like macrophages decreased while M1-like macrophages increased. These findings suggest that metformin activates cancer AMPK-NF-κB signaling, a pathway involved in regulating M1/M2 expression and inducing genes for macrophage polarization to anti-tumor phenotype.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.14982

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

Metadata

Authors
Chiang, C.-F., Chao, T.-T., Su, Y.-F., Hsu, C.-C., Chien, C.-Y., Chiu, K.-C., Shiah, S.-G., Lee, C.-H., Liu, S.-Y., & Shieh, Y.-S.
Venue
Oncotarget
Published
2017-02-01
Volume
8
Issue
13
Pages
20706-20718
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2585139079
Cited by
188
References
7
FWCI
3.14
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.